# Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

> **NCT00846742** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 88 (actual)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **DRUG:** Stanford V Chemotherapy
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00846742
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2009-06-05
- **Primary completion:** 2019-01-11
- **Final completion:** 2028-10
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846742, "Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00846742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*